MarketBeat
10 Aug 2026, 04:03 UTC · 2h ago
Vitalhub Q2 Earnings Call Highlights
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
MarketBeat
10 Aug 2026, 04:03 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
5 claims · each scored for market impact
Vitalhub's annual recurring revenue (ARR) surpassed CAD 100 million for the first time, reaching CAD 101.5 million. — Crossing a major ARR threshold is a key valuation milestone for SaaS-style companies, signaling scalable growth and stability.
+0.60Some U.K. customers suspended use of the SHREWD product due to uncertainty surrounding the NHS's Federated Data Platform and Palantir-based solutions. — Direct revenue attrition and competitive pressure from a dominant player like Palantir create specific risk for the U.K. segment.
-0.40Vitalhub acquired Buddy Healthcare and maintains over CAD 120 million in cash for further acquisitions with no existing debt. — A strong balance sheet and active M&A pipeline provide a cushion for growth and inorganic expansion into new markets.
+0.30Continue reading
6 related stories
Top 2 movers · tap to explore
Q2 2026 revenue grew 33% year-over-year to CAD 31.7 million, with Adjusted EBITDA remaining stable at 26% of revenue. — Strong top-line growth paired with consistent margins demonstrates operational efficiency during expansion.
+0.20The company is developing AI-based transcription and protocoling tools, with revenue from scribing solutions expected by late 2026 or 2027. — While AI adds long-term optionality, the distant revenue horizon limits immediate price impact.
+0.10Which stocks this story touches
Strong revenue growth, ARR surpassing 100 million, and strategic acquisition of Buddy Healthcare, despite some U.K. product headwinds.
Mentioned as a competitor whose NHS Federated Data Platform contract is causing some customers to suspend renewals with Vitalhub.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
The Motley Fool
2h ago
